Touchstone International Medical Science Co Ltd (688013) — Net Asset Quality Index
Touchstone International Medical Science Co Ltd (688013) has a Net Asset Quality Index of 88.7% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥676.02 Million minus total liabilities of CN¥76.41 Million yields net assets of CN¥599.62 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read debt load of Touchstone International Medical Science for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Touchstone International Medical Science Co Ltd Net Asset Quality Index Over Time (2017–2024)
This chart shows how Touchstone International Medical Science Co Ltd's Net Asset Quality Index has evolved across 8 annual periods from 2017 to 2024. As of September 2025, the index stands at 88.7%, representing net assets of CN¥599.62 Million against total assets of CN¥676.02 Million CNY. For live market cap and overall valuation, see Touchstone International Medical Science market cap and net worth.
Annual Net Asset Quality Index for Touchstone International Medical Science Co Ltd (2017–2024)
The table below presents the year-by-year Net Asset Quality Index for Touchstone International Medical Science Co Ltd from 2017 to 2024, covering 8 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check 688013 PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 91.2% | CN¥581.43 Million | CN¥637.24 Million | CN¥55.81 Million | ▲ +0.0 pp |
| 2023 | 91.2% | CN¥571.52 Million | CN¥626.61 Million | CN¥55.08 Million | ▼ -2.3 pp |
| 2022 | 93.6% | CN¥508.41 Million | CN¥543.46 Million | CN¥35.04 Million | ▼ -0.4 pp |
| 2021 | 94.0% | CN¥512.13 Million | CN¥544.83 Million | CN¥32.71 Million | ▼ -2.0 pp |
| 2020 | 96.0% | CN¥465.89 Million | CN¥485.24 Million | CN¥19.35 Million | ▲ +10.2 pp |
| 2019 | 85.8% | CN¥107.18 Million | CN¥124.91 Million | CN¥17.72 Million | ▲ +14.9 pp |
| 2018 | 70.9% | CN¥82.90 Million | CN¥116.95 Million | CN¥34.05 Million | ▼ -10.1 pp |
| 2017 | 81.0% | CN¥79.84 Million | CN¥98.57 Million | CN¥18.72 Million | — |